66 related articles for article (PubMed ID: 23279665)
1. ABCB1/MDR1 gene polymorphism and colorectal cancer risk: a meta-analysis of case-control studies.
He T; Mo A; Zhang K; Liu L
Colorectal Dis; 2013 Jan; 15(1):12-8. PubMed ID: 23279665
[TBL] [Abstract][Full Text] [Related]
2. Association of MDR1 G2677T polymorphism and leukemia risk: evidence from a meta-analysis.
Yan Y; Liang H; Xie L; He Y; Li M; Li R; Li S; Qin X
Tumour Biol; 2014 Mar; 35(3):2191-7. PubMed ID: 24142546
[TBL] [Abstract][Full Text] [Related]
3. Effects of genetic polymorphisms of MDR1, FMO3 and CYP1A2 on susceptibility to colorectal cancer in Koreans.
Bae SY; Choi SK; Kim KR; Park CS; Lee SK; Roh HK; Shin DW; Pie JE; Woo ZH; Kang JH
Cancer Sci; 2006 Aug; 97(8):774-9. PubMed ID: 16800822
[TBL] [Abstract][Full Text] [Related]
4. Association between ABCB1 polymorphisms and haplotypes and Alzheimer's disease: a meta-analysis.
Zhong X; Liu MY; Sun XH; Wei MJ
Sci Rep; 2016 Sep; 6():32708. PubMed ID: 27600024
[TBL] [Abstract][Full Text] [Related]
5. No influence of ABCB1 haplotypes on methadone dosage requirement.
Crettol S; Déglon JJ; Besson J; Croquette-Krokar M; Hämmig R; Gothuey I; Monnat M; Eap CB
Clin Pharmacol Ther; 2008 May; 83(5):668-9; author reply 669-70. PubMed ID: 18043693
[No Abstract] [Full Text] [Related]
6. Genome-wide association data suggest ABCB1 and immune-related gene sets may be involved in adult antisocial behavior.
Salvatore JE; Edwards AC; McClintick JN; Bigdeli TB; Adkins A; Aliev F; Edenberg HJ; Foroud T; Hesselbrock V; Kramer J; Nurnberger JI; Schuckit M; Tischfield JA; Xuei X; Dick DM
Transl Psychiatry; 2015 Apr; 5(4):e558. PubMed ID: 25918995
[TBL] [Abstract][Full Text] [Related]
7. ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: a comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas.
Johnatty SE; Beesley J; Gao B; Chen X; Lu Y; Law MH; Henderson MJ; Russell AJ; Hedditch EL; Emmanuel C; Fereday S; Webb PM; ; Goode EL; Vierkant RA; Fridley BL; Cunningham JM; Fasching PA; Beckmann MW; Ekici AB; Hogdall E; Kjaer SK; Jensen A; Hogdall C; Brown R; Paul J; Lambrechts S; Despierre E; Vergote I; Lester J; Karlan BY; Heitz F; du Bois A; Harter P; Schwaab I; Bean Y; Pejovic T; Levine DA; Goodman MT; Camey ME; Thompson PJ; Lurie G; Shildkraut J; Berchuck A; Terry KL; Cramer DW; Norris MD; Haber M; MacGregor S; deFazio A; Chenevix-Trench G
Gynecol Oncol; 2013 Oct; 131(1):8-14. PubMed ID: 23917080
[TBL] [Abstract][Full Text] [Related]
8. Association of ABCB1 Polymorphisms with Efficacy and Adverse Drug Reactions of Valproic Acid in Children with Epilepsy.
Zhu J; Lu J; He Y; Shen X; Xia H; Li W; Zhang J; Fan X
Pharmaceuticals (Basel); 2023 Oct; 16(11):. PubMed ID: 38004402
[TBL] [Abstract][Full Text] [Related]
9. Low Blood-As Levels and Selected Genotypes Appears to Be Promising Biomarkers for Occurrence of Colorectal Cancer in Women.
Baszuk P; Stadnik P; Marciniak W; Derkacz R; Jakubowska A; Cybulski C; Huzarski T; Gronwald J; Dębniak T; Białkowska K; Pietrzak S; Kładny J; Scott RJ; Lubiński J; Lener MR
Biomedicines; 2021 Aug; 9(9):. PubMed ID: 34572288
[TBL] [Abstract][Full Text] [Related]
10. ABCB1 and ABCG2 restricts the efficacy of gedatolisib (PF-05212384), a PI3K inhibitor in colorectal cancer cells.
Liu C; Xing W; Yu H; Zhang W; Si T
Cancer Cell Int; 2021 Feb; 21(1):108. PubMed ID: 33593355
[TBL] [Abstract][Full Text] [Related]
11. Sapitinib Reverses Anticancer Drug Resistance in Colon Cancer Cells Overexpressing the ABCB1 Transporter.
Gao HL; Gupta P; Cui Q; Ashar YV; Wu ZX; Zeng L; Lei ZN; Teng QX; Ashby CR; Guan Y; Chen ZS
Front Oncol; 2020; 10():574861. PubMed ID: 33163405
[TBL] [Abstract][Full Text] [Related]
12. Association between
Al-Ghafari AB; Al Qahtani AM; Alturki SN; Al Doghaither HA; Elmorsy EM; Tashkandi HM; Abusanad AM; Alkhayyat SS; Omar UM; Zeeneldin AA
Oncol Lett; 2020 Nov; 20(5):155. PubMed ID: 32934723
[TBL] [Abstract][Full Text] [Related]
13. Impact of genetic variants of ABCB1, APOB, CAV1, and NAMPT on susceptibility to pancreatic ductal adenocarcinoma in Chinese patients.
Li B; Zhang C; Wang J; Zhang M; Liu C; Chen Z
Mol Genet Genomic Med; 2020 Jun; 8(6):e1226. PubMed ID: 32243098
[TBL] [Abstract][Full Text] [Related]
14.
Al Qahtani AM; Al-Ghafari AB; Al Doghaither HA; Alzahrani AH; Omar UM; Rahimulddin SA
Afr Health Sci; 2019 Sep; 19(3):2476-2483. PubMed ID: 32127820
[TBL] [Abstract][Full Text] [Related]
15. Association between ABCB1 (3435C>T) polymorphism and susceptibility of colorectal cancer: A meta-analysis.
Han LL; Zuo BL; Cai WL; Guo ZN; Tong BH; Wei HL; Zhu Z; Li GY
Medicine (Baltimore); 2020 Feb; 99(8):e19189. PubMed ID: 32080102
[TBL] [Abstract][Full Text] [Related]
16. Association between ABCB1, ABCG2 carrier protein and COX-2 enzyme gene polymorphisms and breast cancer risk in a Turkish population.
Zeliha KP; Dilek O; Ezgi O; Halil K; Cihan U; Gul O
Saudi Pharm J; 2020 Feb; 28(2):215-219. PubMed ID: 32042261
[TBL] [Abstract][Full Text] [Related]
17. Common variants in glucuronidation enzymes and membrane transporters as potential risk factors for colorectal cancer: a case control study.
Falkowski S; Woillard JB; Postil D; Tubiana-Mathieu N; Terrebonne E; Pariente A; Smith D; Guimbaud R; Thalamas C; Rouguieg-Malki K; Marquet P; Picard N
BMC Cancer; 2017 Dec; 17(1):901. PubMed ID: 29282011
[TBL] [Abstract][Full Text] [Related]
18. MDR1A deficiency restrains tumor growth in murine colitis-associated carcinogenesis.
Hennenberg EM; Eyking A; Reis H; Cario E
PLoS One; 2017; 12(7):e0180834. PubMed ID: 28686677
[TBL] [Abstract][Full Text] [Related]
19. Synergistic anticancer effect of exogenous wild-type p53 gene combined with 5-FU in human colon cancer resistant to 5-FU in vivo.
Xie Q; Wu MY; Zhang DX; Yang YM; Wang BS; Zhang J; Xu J; Zhong WD; Hu JN
World J Gastroenterol; 2016 Aug; 22(32):7342-52. PubMed ID: 27621580
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
